Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $15.11 $17.90 Friday, 10th May 2024 ACAD stock ended at $15.25. This is 0.263% more than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 2.78% from a day low at $15.11 to a day high of $15.53.
90 days $15.11 $26.78
52 weeks $15.11 $33.91

Historical ACADIA Pharmaceuticals Inc. prices

Date Open High Low Close Volume
Jul 07, 2016 $33.51 $33.51 $33.51 $33.51 1 122 000
Jul 06, 2016 $33.61 $33.61 $33.61 $33.61 1 408 300
Jul 05, 2016 $32.64 $32.64 $32.64 $32.64 2 012 500
Jul 01, 2016 $34.25 $34.25 $34.25 $34.25 1 894 500
Jun 30, 2016 $32.46 $32.46 $32.46 $32.46 1 652 800
Jun 29, 2016 $32.38 $32.38 $32.38 $32.38 1 874 800
Jun 28, 2016 $31.66 $31.66 $31.66 $31.66 2 193 600
Jun 27, 2016 $30.30 $30.30 $30.30 $30.30 2 787 900
Jun 24, 2016 $31.43 $31.43 $31.43 $31.43 9 672 300
Jun 23, 2016 $33.50 $33.50 $33.50 $33.50 2 610 900
Jun 22, 2016 $33.50 $33.50 $33.50 $33.50 3 401 600
Jun 21, 2016 $34.99 $34.99 $34.99 $34.99 3 554 900
Jun 20, 2016 $37.40 $37.40 $37.40 $37.40 1 898 200
Jun 17, 2016 $37.41 $37.41 $37.41 $37.41 2 931 300
Jun 16, 2016 $38.35 $38.35 $38.35 $38.35 1 754 478
Jun 15, 2016 $38.17 $38.17 $38.17 $38.17 2 163 259
Jun 14, 2016 $39.21 $39.21 $39.21 $39.21 2 157 086
Jun 13, 2016 $38.10 $38.10 $38.10 $38.10 3 114 016
Jun 10, 2016 $39.60 $39.60 $39.60 $39.60 2 751 118
Jun 09, 2016 $40.21 $40.21 $40.21 $40.21 2 736 526
Jun 08, 2016 $41.55 $41.55 $41.55 $41.55 2 395 282
Jun 07, 2016 $40.58 $40.58 $40.58 $40.58 2 631 217
Jun 06, 2016 $40.68 $40.68 $40.68 $40.68 5 696 265
Jun 03, 2016 $36.07 $36.07 $36.07 $36.07 2 859 735
Jun 02, 2016 $36.81 $36.81 $36.81 $36.81 2 785 326
Click to get the best stock tips daily for free!

About ACADIA Pharmaceuticals Inc.

ACADIA Pharmaceuticals. ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in central nervous system disorders. The company offers NUPLAZID (pimavanserin) for the treatment of hallucinations and delusions associated with Parkinson's disease psychosis. It's pipeline include, pimavanserin, under phase 3 development for the treatment of Alzheimer's disease psych... ACAD Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT